Completed
A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)
NCT02637557
- Conditions
- Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
- Locations
-
- IW-3718 Investigator Dothan, Alabama, United States
- IW-3718 Investigator Phoenix, Arizona, United States
- IW-3718 Investigator Tucson, Arizona, United States
- IW-3718 Investigator Tucson, Arizona, United States